Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01351688 | An Open Label Prostate Cancer Study in Japanese Patients | completed | Phase 1 | 13 | AstraZenecaINDUSTRY | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00006078 | Lycopene In Preventing of Prostate Cancer | completed | Phase 1 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00093561 |
| Lycopene in Preventing Prostate Cancer in Healthy Participants |
| completed |
| Phase 1 |
| — |
| University of Illinois at ChicagoOTHER |
| 1 |
| Jun 26, 2013 |
| clinicaltrials |
| NCT00416325 | Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer | completed | Phase 1 | 18 | University of Illinois at ChicagoOTHER | 0 | Jun 26, 2013 | clinicaltrials |
| NCT00002480 | Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002637 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003394 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 1 / Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00025194 | Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004928 | Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005634 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006380 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT01228760 | A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer | completed | Phase 1 | 46 | Astellas Pharma IncINDUSTRY | 1 | Jun 7, 2013 | clinicaltrials |
| NCT00061867 | Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | ImunonINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT01664728 | An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 | completed | Phase 1 | 54 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00600535 | A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer | completed | Phase 1 | 31 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Apr 17, 2013 | clinicaltrials |
| NCT00910754 | A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 33 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT01017939 | A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 34 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00039299 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00036933 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00004211 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 17 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00666926 | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | completed | Phase 1 | 99 | Verastem, Inc.INDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00003819 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00016146 | Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00314782 | Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 3 | Mar 12, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01522118 | MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease | completed | Phase 1 | 12 | University of Roma La SapienzaOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT00882232 | Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer | completed | Phase 1 | 10 | Cancer Center of IrvineOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00004029 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004929 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00005632 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00939510 | Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 32 | Robert Dreicer MDOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00006044 | Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00289341 | Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. | completed | Phase 1 / Phase 2 | 24 | Rockefeller UniversityOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004879 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00005048 | Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00616291 | Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer | completed | Phase 1 | 14 | Baylor College of MedicineOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00065208 | Reiki/Energy Healing in Prostate Cancer | completed | Phase 1 / Phase 2 | 79 | The Cleveland ClinicOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00038168 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00790595 | Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy | completed | Phase 1 | 6 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00448695 | MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer | completed | Phase 1 | 12 | University Health Network, TorontoOTHER | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00895115 | Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer | completed | Phase 1 | 65 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00075192 | CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer | completed | Phase 1 / Phase 2 | 8 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00653757 | Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | completed | Phase 1 / Phase 2 | 100 | Mayo ClinicOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00403221 | Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer | completed | Phase 1 | 19 | Baylor College of MedicineOTHER | 1 | Feb 10, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jul 3, 2013source: clinicaltrials